About Biogelx
Biogelx is a company based in Lanark (United Kingdom) founded in 2012. Biogelx has raised $983 thousand across 2 funding rounds from investors including University of Strathclyde, Scottish Enterprise and European Union. The company has 10 employees as of January 31, 2019. Biogelx offers products and services including Healthcare Blog, Articles on Nanomedicine, and Biomaterials Posts. Biogelx operates in a competitive market with competitors including Gel Coat Biomaterials, SPES Tech, Matrix Bio, PepGel and Sumatrix Biotech, among others.
- Headquarter Lanark, United Kingdom
- Employees 10 as on 31 Jan, 2019
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biogelx Limited
- Date of Incorporation 17 Aug, 2012
- Jurisdiction 95 HAYMARKET TERRACE, EDINBURGH
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$983 K (USD)
in 2 rounds
-
Latest Funding Round
$275.28 K (USD), Grant
Mar 01, 2018
-
Investors
University of Strathclyde
& 3 more
-
Employee Count
10
as on Jan 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biogelx
Biogelx offers a comprehensive portfolio of products and services, including Healthcare Blog, Articles on Nanomedicine, and Biomaterials Posts.
Platform for articles on medical technologies and innovations
In-depth coverage of advancements in nanomedicine applications
Discussions on biomaterials in regenerative medicine
Funding Insights of Biogelx
Biogelx has successfully raised a total of $983K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $275.28 thousand completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biogelx
Biogelx has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include University of Strathclyde, Scottish Enterprise and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investment is provided to promising Scottish entrepreneurs.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Public university offering multiple degrees and courses across diversified streams
|
Locked | Locked | Locked |
Investor details for Biogelx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biogelx
Investment portfolio details for Biogelx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biogelx
Detailed financials for Biogelx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biogelx Comparisons
Peer comparison for Biogelx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biogelx
Biogelx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gel Coat Biomaterials, SPES Tech, Matrix Bio, PepGel and Sumatrix Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hydrogel technology is developed for biomaterials and medical uses.
|
|
| Locked | Locked | Locked |
Develops recombinant protein hydrogel technology for cell culture applications.
|
|
| Locked | Locked | Locked |
Develops AI tools for optimizing hydrogels in 3D cell culture research.
|
|
| Locked | Locked | Locked |
Self-healing hydrogels for 3D cell culture are developed and commercialized.
|
|
| Locked | Locked | Locked |
Produces high-quality hydrogel materials for various applications.
|
Detailed competitors of Biogelx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biogelx
Complete news archive for Biogelx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biogelx
Biogelx was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Biogelx is headquartered in Lanark, United Kingdom. It is registered at Lanark, South Lanarkshire, United Kingdom.
Biogelx is a funded company, having raised a total of $983K across 2 funding rounds to date.
As of Jan 31, 2019, the latest employee count at Biogelx is 10.
Biogelx is a biomaterials company which supplies peptide hydrogels for cell culture. Its products include lyophilized peptide powder, plus protocols for gel preparation are patented and are currently selling in the US, Europe and Asia. It claims that its products have applications in cell research, toxicologydrug development, 3D printing and also cell therapyregenerative medicine. It also states that biogelx gels can be structured to control mesenchymal stem cell differentiation and to develop in vitro models for cancer research.
Biogelx's top competitors include Gel Coat Biomaterials, PepGel and SPES Tech.
Biogelx offers Healthcare Blog, Articles on Nanomedicine, and Biomaterials Posts.
Biogelx has 4 investors. Key investors include University of Strathclyde, Scottish Enterprise, European Union, and Gabriel Investment Syndicate.